Cargando…
Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant Depression
INTRODUCTION: COMP360 is a synthetic, proprietary, purified form of psilocybin in development for treatment-resistant depression (TRD) with FDA Breakthrough Therapy designation. In a recent phase IIb study, COMP360 psilocybin 25mg was superior to 1mg on change from baseline (CFB) to Week 3 on the Mo...
Autores principales: | Goodwin, G. M., Marwood, L., Mistry, S., Nowakowska, A., Simmons, H., Tsai, J., Williams, S., Young, M. B., Malievskaia, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595939/ http://dx.doi.org/10.1192/j.eurpsy.2023.273 |
Ejemplares similares
-
Clinical utility of the Montgomery-Åsberg Depression Rating Scale for the detection of depression among bariatric surgery candidates
por: Duarte-Guerra, Leorides Severo, et al.
Publicado: (2016) -
Psychometric evaluation of the Malay version of the Montgomery- Asberg Depression Rating Scale (MADRS-BM)
por: Yee, Anne, et al.
Publicado: (2015) -
Validity and test–retest reliability of the Persian version of the Montgomery–Asberg Depression Rating Scale
por: Ahmadpanah, Mohammad, et al.
Publicado: (2016) -
The self-reported Montgomery-Åsberg depression rating scale is a useful evaluative tool in major depressive disorder
por: Fantino, Bruno, et al.
Publicado: (2009) -
The course of depression in late life as measured by the Montgomery and Asberg Depression Rating Scale in an observational study of hospitalized patients
por: Borza, Tom, et al.
Publicado: (2015)